Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketanest versus etomidate for intubation in septic shock
NL-OMON28809Recruiting
- Sponsor
- departemental funding
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in septic shock comparing Ketanest arm with Etomidate control arm (2 arms). Primary endpoints: Central venous pressure, Heart rate and blood pressure and 6 more. Started Feb 2009; status: recruiting.
02
Drugs
esketamineetomidate
03
Conditions
septic shock
Beyond the preview
Go deeper on NL-OMON28809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28809.